EN IT

BEAM — Beam Therapeutics, Inc. | Setup 6-10 Jul 2026

BEAM
Beam Therapeutics, Inc.
Updated: 2026-07-12 · [ 6-10 Jul 2026 ]
📅 Earnings · Aug 11, 2026 · in 30d
Stock · US
Inside composite NTZ, transitioning bias
SCORE IQS Lite
48/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 20
Daily Momentum 6
Weekly Ichimoku 19
Daily CMF 3
Delta 0
IQS Lite components · score
STRUCTURE20/30MOMENTUM6/35ICHIMOKU19/19CMF3/6DELTA0/10

IQS Lite analysis · Beam Therapeutics, Inc. (BEAM)

Weekly Structure
At 20/30 structure is solid: moving averages aligned and underlying trend intact.
Daily Momentum
At 6/35 momentum is absent: flat or negative daily impulse, no acceleration.
Weekly Ichimoku
At 19/19 Ichimoku is fully bullish: above the cloud with Tenkan and Kijun aligned.
Daily CMF
At 3/6 CMF is neutral: balance between capital inflows and outflows.
Delta
At 0/10 the week is sharply down: weekly performance below -2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
The weekly structure remains supported by strong bullish MACD, but the cycle has entered a mature phase requiring caution on potential exhaustion. Price sits inside the neutral compression, between NTZ_inf and NTZ_sup, awaiting confirmation of the breakout. Daily MACD shows bullish fading.
This week's view
BEAM sits in consolidation within the neutral technical zone, with daily MACD in strong bearish and weekly MACD in bullish fading. Recovery remains interesting only on confirmed breakout above 35.40, while the yellow flag suggests awaiting structural confirmation before engaging.
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn